Chief Executive Officer (CEO) Mr. Allen Guo 18+ years years of industry and executive experience across pharma and CDMO services, driving new business development, global market expansion, strategic management, and leading highperforming global teams.
Chief Technology Officer (CTO) Dr. Jin Yin 20+ years of industry experience in process development, GMP manufacturing, and life cycle management across clinical and commercial programs involving AAVs, LVVs, mRNA-LNPs, antibodies, fusion proteins, recombinant enzymes, and vaccines.
Chief Quality Officer (CQO) Dr. Chris Yan 30+ years of experience in process development, manufacturing, regulatory submissions, and quality management, with extensive leadership experience in global pharmaceutical and biotech companies.
Chief Operating Officer (COO) Mr. Simon Wu 18+ years of experience in research, development, manufacturing, and operations management in the fields of antibody drugs and cell gene therapy, as well as leadership experience in leading global biotech company.
VP, Head of Discovery Dr. Yu Liang 20+ years of research experience in biomedical science in academia and industry, with 10+ years of managerial experience in leading pharmaceutical companies.
VP, Head of Biologics Mr. Felix Zhu 20+ years of experience in biologics development, with 10+ years of managerial experience in leading antibody process development.
VP, Head of Global Marketing Dr. Millie Ullah 20+ years of experience in life sciences and biopharma with deep expertise leading global teams to revolutionize go-to-market strategies through compelling customer and market insights, data-driven analysis and execution.
Sr. Director, CNBD Dr. Andy Liu 15+ years of experience in biological research and development, project management and business development.
Sr. Director, USBD Dr. Julia Su 15+ years of experience spanning biological and viral vector research, strategic client management, and business development leadership in the biotech and CDMO sectors.
Director, APBD Dr. Yuyuan Dai 10+ years years of research experience in oncology sciences in academia, combined with more than 6 years of industry experience, including over 3 years in leadership and management roles within the CDMO and business development environment.
Sr. Director, EUBD Dr. Qingyu Cao 20+ years of commercial experiences in biologics drug discovery, development and manufacture in a global CDMO market, as well as knowledge in commercialization of technology innovations, licensing of manufacture platform technologies, growth strategies and business development.
Sr. Director, PM Dr. Amy Sun 15+ years of research experience in biomedical science across academia and industry, including 10 years of leadership in CMC project management.